BioVision

Milpitas, United States Founded: 1999 • Age: 27 yrs Acquired By Abcam
Develops assay kits, antibodies, proteins enzymes, and other research tools.
Annual revenue - Latest available
Total funding - 1 rounds
Employees 65 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About BioVision

BioVision is a company based in Milpitas (United States) founded in 1999 was acquired by Abcam in August 2021. The company has 65 employees as of December 31, 2022. BioVision operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.

  • Headquarter Milpitas, United States
  • Employees 65 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Biovision Incorporated
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    65

    as on Dec 31, 2022

  • Acquired by
    Abcam

    (Aug 02, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of BioVision

Investors in BioVision

BioVision has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abcam.

All
Institutional
Investor Description Founded Year Domain Location
Biological reagents and antibodies are developed for life science research.
Locked Locked Locked
Premium access

Investor details for BioVision

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BioVision

Investments
Premium access

Investment portfolio details for BioVision

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - BioVision

Premium access

Detailed financials for BioVision

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Biovision Comparisons

BioVision Primary company
Description
Develops assay kits, antibodies, proteins & enzymes, and oth...
Location
Milpitas, United States
Founded Year
1999
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
65
As of 2022
Premium access

Peer comparison for BioVision

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of BioVision

BioVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Biological reagents and antibodies are developed for life science research.
Locked Locked Locked
Developer of cell culture media and ancillary reagents for life science research
Locked Locked Locked
Reagents and instruments are provided for life sciences research.
Locked Locked Locked
Reagents and kits are provided for clinical research applications.
Locked Locked Locked
Develops tools and products for research and clinical application
Locked Locked Locked
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
Premium access

Detailed competitors of BioVision

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Biovision

Premium access

Complete news archive for BioVision

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioVision

BioVision was founded in 1999 and raised its 1st funding round 25 years after it was founded.

BioVision is headquartered in Milpitas, United States. It is registered at Milpitas, California, United States.

As of Dec 31, 2022, the latest employee count at BioVision is 65.

BioVision was founded in 1999 in Milpitas, United States, within the biotechnology sector. Products such as assay kits, antibodies, recombinant proteins, and enzymes are developed for research into apoptosis, metabolism, cell proliferation, cellular stress, cell damage, and repair. These research tools are offered and distributed to customers in more than 60 countries worldwide.

BioVision's top competitors include Abcam, Sino Biological and Meridian Bioscience.

BioVision has 1 investor. Key investors include Abcam.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available